Abcellera Biologics Inc at Credit Suisse Healthcare Conference Transcript
© -
All right. So welcome, everyone, to the 31st Annual Healthcare Conference Credit Suisse. I'm Tiago Fauth. I'm a biotech analyst at Credit Suisse, joined today by AbCellera. We have Andrew Booth, CFO of the company, for a fireside chat. So an informal conversation about the company for the next 25 minutes or so. Nice to see you in person finally.
Finally, yes, a couple of years of working together.
© -
I always like to give you guys a couple of minutes to talk bigger picture about AbCellera business model, big picture things, and I'm going to have several detailed follow-ups after that. But yes, if you could talk -- it's a name that is a little bit unusual from a business model perspective. So I don't know if everyone is super familiar with it. So can you give us the 2
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
